The Translational Genomics Research Institute

The Translational Genomics Research Institute (TGen), is a non-profit genomics research institute established in 2002 by Jeffrey Trent, the founding Scientific Director of the National Human Genome Research Institute (NHGRI), in Phoenix, Arizona, United States. TGen seeks to employ genetic discoveries to improve disease outcomes by developing smarter diagnostics and targeted therapeutics. TGen conducts research on a number of human disorders including Alzheimer's disease, Autism, Parkinson's, Diabetes and numerous forms of cancer and a variety of other complex human diseases. This internationally recognized institute has helped to generate a strong foundation for Arizona's growing role in scientific research and cutting edge biotechnology. The emerging field of translational genomics research harnesses the power of new discoveries resulting from the Human Genome Project and applying them to the development of improved diagnostics, prognostics and therapies for cancer, neurological disorders, diabetes and other complex diseases.

Address
Phoenix, Arizona, United States of America
Website
http://www.tgen.org/

Subscribe to rss feed

Medical research

New 'liquid biopsy' blood test improves breast cancer diagnostics

A new type of blood test for breast cancer could help avoid thousands of unnecessary surgeries and otherwise precisely monitor disease progression, according to a study led by the Translational Genomics Research Institute ...

Diseases, Conditions, Syndromes

TGen-led study finds link between gene and severe liver damage

Researchers have found that a gene known as AEBP1 may play a central role in the development, severity and potential treatment of liver disease, according to a study by Temple University, the Geisinger Obesity Institute and ...

Oncology & Cancer

TGen review links gene with the most common liver cancer

Hepatocellular carcinoma (HCC) is a long medical name for the most common form of liver cancer, a malignancy whose incidence has nearly doubled over the past decade, making it the fastest growing type of cancer in the U.S., ...

Diseases, Conditions, Syndromes

TGen and ABL pursue global rollout of advanced TB test

In an important step toward eradicating tuberculosis (TB), the Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has signed a licensing agreement with an international biomedical firm, Advanced ...

Diseases, Conditions, Syndromes

Outbreak of paralyzing disease linked to non-polio enterovirus

The Translational Genomics Research Institute (TGen), an affiliate of City of Hope, has identified a polio-like virus as a potential cause of an outbreak of a disease known as Acute Flaccid Myelitis (AFM), a crippling condition ...

page 1 from 9